Test Price
2,800 AED✅ Home Collection Available
ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetics specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ATP1A2 NGS test screens the entire coding region of the ATP1A2 gene for pathogenic variants linked to Familial Hemiplegic Migraine Type 2 (FHM2). Using high-coverage Next‑Generation Sequencing with 30x depth and CNV analysis, we deliver clinically actionable results with a turnaround of 3 to 4 weeks. This test is critical for confirming FHM2 diagnosis, guiding treatment, and assessing familial risk.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision | Full gene NGS (100% coverage, 30x depth) | Sanger sequencing (targeted exons, lower resolution) |
| Method | Next‑Generation Sequencing with CNV analysis | Single‑gene sequencing, no copy‑number detection |
| Turnaround | 3–4 Weeks (ISO cold chain) | 4–6 Weeks |
Physician Insight & Safety Protocols
"The ATP1A2 genetic test provides a definitive molecular diagnosis for Familial Hemiplegic Migraine Type 2, which can be life-changing for patients and their families. However, a negative result does not exclude all genetic migraine disorders. I strongly recommend correlating these findings with a detailed family history and clinical presentation before making therapeutic decisions." – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not adjust, start, or discontinue any prescribed medication for migraine or other conditions without consulting your treating physician.
Safety Exclusion Criteria & Red Flags
- Patient currently hospitalized or in an acute neurological crisis – schedule test post-stabilization.
- Known allergy to phlebotomy antiseptics – inform the mobile team in advance.
- Weight < 5 kg in pediatric patients – risk of excessive blood draw; alternative DNA sources (buccal swab) may be considered.
- ER Red Flags: Sudden onset of paralysis, confusion, or loss of consciousness – proceed to nearest emergency room immediately.
Patient FAQ & Clinical Guidance
1. What is the ATP1A2 gene test and how is it performed?
This test uses Next-Generation Sequencing to detect mutations in the ATP1A2 gene from a standard blood draw or FTA card, providing a definitive diagnosis of familial hemiplegic migraine type 2. A detailed report is produced within 3–4 weeks.
2. How long must I wait for the results and what will they tell me?
A molecular report is delivered within 3–4 weeks, clearly stating whether a pathogenic or likely pathogenic ATP1A2 variant was identified, along with clinical correlation notes from our genetics specialist. Results are securely transmitted via encrypted portal or printed copy.
3. Is the test covered by UAE insurance and how do I verify?
We offer direct insurance billing verification via WhatsApp at +971 54 548 8731. Our team will confirm your coverage under DHA‑recognised policies before the sample collection. Please have your policy number and ID ready.
UAE Regulatory & Data Privacy Adherence
Compliance & Data Protection
All genetic testing and personal data handling at DNA Labs UAE are fully compliant with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and processing of genetic and health data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure digital transmission and storage of medical records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – providing the legal framework for clinical responsibility and patient consent.
Our facility is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and operates under DHA license number 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | ATP1A2 Gene Familial Hemiplegic Migraine Type 2 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks (from sample receipt at laboratory) |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) or FTA card; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis, 30x average depth, full coding region coverage |
| ICD-10-CM Code | G43.1, G43.10, G43.11 |
| LOINC Code | 48000-6 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab Brand: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians